<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03111758</url>
  </required_header>
  <id_info>
    <org_study_id>NL59864.068.16</org_study_id>
    <nct_id>NCT03111758</nct_id>
  </id_info>
  <brief_title>Flow Augmentation Study in Postthrombotic Patients</brief_title>
  <official_title>Flow Augmentation With Geko Device in Patients With Postthrombotic Syndrome a Prospective Randomised Cross-Over Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale:

      Stent therapy has been proven to be an effective form of therapy in the treatment of chronic
      iliofemoral and iliocaval post-thrombotic obstruction. During the first post-intervention day
      intermittent pneumatic compression stockings (IPCS) are necessary to augment venous flow.
      This will inherently prevent early stent occlusion. Our aim is to investigate whether the
      Geko device is effective as IPCS regarding augmentation of flow in post-thrombotic patients
      during the first day after stenting.

      Objective: The primary objective of this study is to identify whether the Geko system is
      effective in augmenting flow compared to IPCS in post-thrombotic limbs before after stenting.

      Study design: Interventional pilot study with randomized cross-sectional design.

      Study population: Patients with a post-thrombotic obstruction undergoing a percutaneous
      procedure (PTA, stenting).

      Intervention (if applicable): Treatment with intermittent pneumatic compression stockings
      (IPCS) and Geko-device.

      Main study parameters/endpoints: The main endpoint and parameter of this study is
      time-averaged maximum flow velocity (TAMFV), measured by duplex ultrasonography using its
      pulse wave Doppler function.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 3, 2017</start_date>
  <completion_date type="Anticipated">October 30, 2017</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time Averaged Maximum Flow Velocity</measure>
    <time_frame>Five times one minute measurement</time_frame>
    <description>time-averaged maximum flow velocity (TAMFV), measured by duplex ultrasonography (DUS) using its pulse wave Doppler function</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Postthrombotic Syndrome</condition>
  <arm_group>
    <arm_group_label>Geko Device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Neuromuscular Stimulator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IPCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intermittent Pneumotic Compression Stocking</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Flow augmentation</intervention_name>
    <description>Augmenting venous flow following deep venous stenting in patients with Postthrombotic syndrome</description>
    <arm_group_label>Geko Device</arm_group_label>
    <arm_group_label>IPCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Post-thrombotic obstruction that requires percutaneous intervention through stenting,
             minimally 18 years of age

        Exclusion Criteria:

          -  Peripheral arterial disease, comorbidities leading to impaired muscle function of
             either lower limb, co-morbidities affecting the circulatory system, history of deep
             venous surgery in either lower limb or groin, allergies to the plasters, pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cees Wittens, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suat Doganci, MD</last_name>
    <phone>+31654637963</phone>
    <email>suat.doganci@mumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maastricht UMC</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suat Doganci, Md</last_name>
      <phone>+31654637963</phone>
      <email>suat.doganci@mumc.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Summers JA, Clinch J, Radhakrishnan M, Healy A, McMillan V, Morris E, Rua T, Ofuya M, Wang Y, Dimmock PW, Lewis C, Peacock JL, Keevil SF. The gekoâ„¢ electro-stimulation device for venous thromboembolism prophylaxis: a NICE medical technology guidance. Appl Health Econ Health Policy. 2015 Apr;13(2):135-47. doi: 10.1007/s40258-014-0139-0.</citation>
    <PMID>25403719</PMID>
  </reference>
  <results_reference>
    <citation>Williams KJ, Moore HM, Davies AH. Haemodynamic changes with the use of neuromuscular electrical stimulation compared to intermittent pneumatic compression. Phlebology. 2015 Jun;30(5):365-72. doi: 10.1177/0268355514531255. Epub 2014 Apr 10.</citation>
    <PMID>24722790</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <last_update_submitted>May 12, 2017</last_update_submitted>
  <last_update_submitted_qc>May 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Postthrombotic Syndrome</mesh_term>
    <mesh_term>Postphlebitic Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

